Abstract
Neural stem cells are present throughout life and continuously give rise to new neurons and glia cells in the mammalian central nervous system. Accumulating evidence suggests essential roles of micro-environments, or niches, in supporting active neurogenesis from endogenous neural stem cells within restricted regions of the adult brain. These neurogenic niches also regulate different steps of adult neurogenesis in response to physiological and pathological stimulations. Recent studies have identified several cellular niche components, including endothelial cells, astroglia, ependymal cells, immature progeny of NSCs and mature neurons. In this review, we discuss identified niche signals from these cellular components in regulating different steps of adult neurogenesis. We also highlight some of the potential therapeutic targets to be manipulated within neurogenic niche for repair of the adult central nervous system.
Keywords: subventricular zone, central nervous system, GABA transporters, pigment epithelial differentiation factor, hippocampus
CNS & Neurological Disorders - Drug Targets
Title: Cellular Niches for Endogenous Neural Stem Cells in the Adult Brain
Volume: 6 Issue: 5
Author(s): J. Dedrick Jordan, Dengke K. Ma, Guo-li Ming and Hongjun Song
Affiliation:
Keywords: subventricular zone, central nervous system, GABA transporters, pigment epithelial differentiation factor, hippocampus
Abstract: Neural stem cells are present throughout life and continuously give rise to new neurons and glia cells in the mammalian central nervous system. Accumulating evidence suggests essential roles of micro-environments, or niches, in supporting active neurogenesis from endogenous neural stem cells within restricted regions of the adult brain. These neurogenic niches also regulate different steps of adult neurogenesis in response to physiological and pathological stimulations. Recent studies have identified several cellular niche components, including endothelial cells, astroglia, ependymal cells, immature progeny of NSCs and mature neurons. In this review, we discuss identified niche signals from these cellular components in regulating different steps of adult neurogenesis. We also highlight some of the potential therapeutic targets to be manipulated within neurogenic niche for repair of the adult central nervous system.
Export Options
About this article
Cite this article as:
Jordan Dedrick J., Ma K. Dengke, Ming Guo-li and Song Hongjun, Cellular Niches for Endogenous Neural Stem Cells in the Adult Brain, CNS & Neurological Disorders - Drug Targets 2007; 6 (5) . https://dx.doi.org/10.2174/187152707783220866
DOI https://dx.doi.org/10.2174/187152707783220866 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Cholinergic System: An Emerging Drug Target for Schizophrenia
Current Pharmaceutical Design Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)
CNS & Neurological Disorders - Drug Targets A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes
Current Pharmaceutical Design Protein Kinase C Modulates Aurora-kinase Inhibition Induced by CCT129202 in HMC-1560,816 Cell Line
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Major Mental Disorders and Violence: A Critical Update
Current Psychiatry Reviews Hypocholesterolemia
Current Vascular Pharmacology 3D Pharmacophore Based Virtual Screening of A2A Adenosine Receptor Antagonists
Protein & Peptide Letters Chelating Agents for the Sequestration of Mercury(II) and Monomethyl Mercury(II)
Current Medicinal Chemistry Lobeline Docking on AChBP and Nicotinic Receptors: Discriminating Importance of the Pocket Geometry and of the Ligand Configuration
Letters in Drug Design & Discovery Tackling Alzheimer’s Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles
Current Medicinal Chemistry Editorial [Hot Topic:Neurodegenerative Disorders: From Molecules to Man (Part 1) (Guest Editors: Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito)]
CNS & Neurological Disorders - Drug Targets The Evolution of Schizophrenia: A Model for Selection by Infection, with a Focus on NAD
Current Pharmaceutical Design Biophysics of Venous Return from the Brain from the Perspective of the Pathophysiology of Chronic Cerebrospinal Venous Insufficiency
Reviews on Recent Clinical Trials MAP Kinase Pathways in Neuronal Cell Death
CNS & Neurological Disorders - Drug Targets Patent Review on Laser Interference Lithography Technique for Producing Periodic Nanostructure
Recent Patents on Nanotechnology Editorial
Recent Patents on Inflammation & Allergy Drug Discovery Synthesis and Biological Evaluation of 5,6-Dihydro-benzo[c] acridin-7-ol Derivatives as Anti-Alzheimers Disease Drugs
Letters in Drug Design & Discovery Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Placebo Effects in Therapeutic Outcomes
Current Clinical Pharmacology Renal Biopsy Research with Implications for Therapy of Glomerulonephritis
Current Drug Therapy